Ro, which makes erectile dysfunction treatment, rolls out menopause meds

Ro, the company behind the D2C erectile dysfunction brand Roman, launched a new line of menopause meds under the name “Rory.”


March 21, 2019

Yesterday, the telehealth startup Ro launched a new product line called Rory for menopausal women.

Rory, which will offer 6 separate products to treat 4 separate conditions, joins Ro’s other product lines Roman and Zero in a growing, convenience-focused telehealth business.

A series of priceless pivots

Ro started out in 2017 as a company called Roman, offering erectile dysfunction medication on demand.

Then, last September, the company raised $88m and launched a new line of products called Zero designed to help consumers quit smoking. At the launch of Zero, the company also changed its name to “Ro” — because, you know, cigs don’t discriminate. 

The name change seemed a little unnecessary at the time — but now that the company is going after menopausal women, it’s all starting to make sense.

The 2 different directions of Hims and Ro

Ro’s original service, Roman, competed directly with other direct-to-consumer ED products offered by companies like Hims. 

But while Hims chose to double down on its Him-ness with products designed specifically for men (hair-loss, skin care, oral care, etc.), Roman decided to do the opposite — and drop its man-focus.

Now, Ro prioritizes convenience over cohesion: The company uses the same business model — convenient, stigma-free on-demand delivery — to target 3 totally different demographic groups with telehealth products.

Daily briefings, straight to your inbox

Business and tech news in 5 minutes or less

Join over 1 million people who read The Hustle

Psst

How'd Bezos build a billion dollar empire?

In 1994, Jeff Bezos discovered a shocking stat: Internet usage grew 2,300% per year.

Data shows where markets are headed.

And that’s why we built Trends — to show you up-and-coming market opportunities about to explode. Interested?

Join us, it's free.

Look, you came to this site because you saw something cool. But here’s the deal. This site is actually a daily email that covers the important news in business, tech, and culture.

So, if you like what you’re reading, give the email a try.